Inovio Pharmaceuticals (INO): Catalysts On The Horizon
Inovio Pharmaceuticals and their current pipeline, science, technology and the advantages to the DNA platform are reviewed. Read the analysis here.
Source: seekingalpha.com
Stay updated with breaking news from Michael Sumner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Inovio Pharmaceuticals and their current pipeline, science, technology and the advantages to the DNA platform are reviewed. Read the analysis here.
INO earnings call for the period ending June 30, 2022.
Its newly announced cost-saving measures are getting a warm reception.
/PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help protect people from infectious...
The last few years haven't been kind to Inovio Pharmaceuticals.